A futures exchange that Howard Lutnick helped found, back when he was the chief executive officer of Cantor Fitzgerald LP, is ...

An affiliate of Cantor Fitzgerald LP is teaming ... contribute $1.5 billion of Bitcoin to the new company, while Bitfinex, a Tether-affiliated exchange, and SoftBank plan to put in $600 million ...

Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Cantor Fitzgerald increased their ... in a document filed with the Securities & Exchange Commission, which is available through this link.

Cantor Fitzgerald analyst Carter Gould initiated coverage of Vaxcyte (PCVX) with an Overweight rating. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter ...

Tesla, Inc. (NASDAQ:TSLA – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2025 ... in a research note on Tuesday, April 22nd. New Street Research raised shares of Tesla ...

Cantor Fitzgerald, C.A. No. 2024-0146-LWW (Del. Ch. April 10, 2025), the Delaware Court of Chancery rejected the plaintiff’s attempt to distinguish Brookfield in his dilution claim challenging a ...

Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...

Financial markets have successfully navigated many significant economic disruptions in recent years and the current tariff disruption is likely to be no different. Picture: Getty ...

As previously reported, Cantor Fitzgerald analyst Carter Gould upgraded Regeneron (REGN) to Overweight from Neutral with a price target of $695, down from $800, as the analyst took over coverage ...